Search research articles
Contact Us
Filters
Showing results (71-80 of 203) with videos related to
Page
of 21
Sort By:
Circulation
|
March 2, 1999
G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
P M Ridker, C H Hennekens, J P Miletich
Archives of Internal Medicine
|
July 25, 1994
Improved health benefits of increased use of thrombolytic therapy
A M Fendrick, P M Ridker, B S Bloom
Circulation
|
June 4, 1998
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
P M Ridker, R J Glynn, C H Hennekens
Thrombosis and Haemostasis
|
July 1, 1997
Postmenopausal hormone replacement therapy and cardiovascular disease
C U Chae, P M Ridker, J E Manson
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 9, 1999
Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men
L E Rohde, C H Hennekens, P M Ridker
JAMA
|
November 10, 1993
A prospective study of lipoprotein(a) and the risk of myocardial infarction
P M Ridker, C H Hennekens, M J Stampfer
Circulation
|
December 1, 1993
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis
S D Solomon, P M Ridker, E M Antman
JAMA
|
April 26, 1995
Plasma concentration of lipoprotein(a) and the risk of future stroke
P M Ridker, M J Stampfer, C H Hennekens
Journal of the American College of Cardiology
|
July 18, 2000
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening
R F Redberg, N Rifai, L Gee, et al.
JAMA
|
July 4, 2001
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study
M A Albert, E Danielson, N Rifai, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 203) with videos related to
Sort By:
Page
of 21
Circulation
|
March 2, 1999
G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
P M Ridker, C H Hennekens, J P Miletich
Archives of Internal Medicine
|
July 25, 1994
Improved health benefits of increased use of thrombolytic therapy
A M Fendrick, P M Ridker, B S Bloom
Circulation
|
June 4, 1998
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
P M Ridker, R J Glynn, C H Hennekens
Thrombosis and Haemostasis
|
July 1, 1997
Postmenopausal hormone replacement therapy and cardiovascular disease
C U Chae, P M Ridker, J E Manson
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 9, 1999
Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men
L E Rohde, C H Hennekens, P M Ridker
JAMA
|
November 10, 1993
A prospective study of lipoprotein(a) and the risk of myocardial infarction
P M Ridker, C H Hennekens, M J Stampfer
Circulation
|
December 1, 1993
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis
S D Solomon, P M Ridker, E M Antman
JAMA
|
April 26, 1995
Plasma concentration of lipoprotein(a) and the risk of future stroke
P M Ridker, M J Stampfer, C H Hennekens
Journal of the American College of Cardiology
|
July 18, 2000
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening
R F Redberg, N Rifai, L Gee, et al.
JAMA
|
July 4, 2001
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study
M A Albert, E Danielson, N Rifai, et al.
Page
of 21